0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query gbi research diabetes therapeutics market india 2018 rapid uptake dpp iv inhibitors glp 1 agonists.Your search for "" gave back 1530039 results.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at USD 9071.4 million in 2023 and is forecast to a readjusted size of USD...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Short Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
November 2021
Price: USD 2,000.00
DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down...
Catalog:
LPI
February 2023
Price: USD 3,660.00
DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Summary Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2...
Catalog:
HYR
April 2021
Price: USD 2,000.00
The global Diabetes Drugs market size was valued at USD 55070 million in 2023 and is forecast to a readjusted size of USD 78860 million by 2030 with...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Summary Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2...
Catalog:
HYR
August 2021
Price: USD 1,800.00
The global Diabetes Drugs market size was valued at US$ 52360 million in 2023. With growing demand in downstream market, the Diabetes Drugs is...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Dipeptidyl Peptidase-4 Inhibitors market size is expected to reach $ 18780 million by 2029, rising at a market growth of 5.2% CAGR during...
Catalog:
GIR
May 2023
Price: USD 4,480.00
The global Dipeptidyl Peptidase-4 Inhibitors market size is projected to grow from US$ 12520 million in 2022 to US$ 18380 million in 2029; it is...
Catalog:
LPI
April 2023
Price: USD 3,660.00
Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017 Summary GBI Research’s latest...
CBR Pharma Insights
June 2017
Price: USD 2,995.00
